Results 151 to 160 of about 32,714,285 (374)

A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the whole systems demonstrator cluster randomised trial [PDF]

, 2011
Peter Bower, Martin Cartwright, Shashivadan P. Hirani, James Barlow, Jane Hendy, Martín Knapp, Catherine Henderson, Anne Rogers, Caroline Sanders, Martin Bardsley, Adam Steventon, Ray Fitzpatrick, Helen Doll, Stanton Newman   +13 more
openalex   +1 more source

Evaluation of an Audio-Video Multimodal Deepfake Dataset using Unimodal and Multimodal Detectors [PDF]

, 2021
Hasam Khalid, Min-Ha Kim, Shahroz Tariq, Simon S. Woo   +3 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Detecting Elemental Impurities by Inductively Coupled Plasma Mass Spectrometry in Russian Radiopharmaceuticals

Регуляторные исследования и экспертиза лекарственных средств
INTRODUCTION. Radiopharmaceutical manufacturers should assess potential negative impact of elemental impurities on the quality of their products using real data of their elemental contamination.
Yu. N. Shvetsova, A. A. Erina, V. M. Shchukin, N. E. Kuz'mina, R. D. Ruziev, D. A. Pripadchev, M. A. Kuznetsov   +6 more
doaj   +1 more source

AN EVALUATION OF STUDIES ON ULTRASTRUCTURE OF TONOPLAST IN SIEVE ELEMENTS

, 1962
Katherine Esau, Vernon I. Cheadle
openalex   +2 more sources

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms [PDF]

, 2018
Patrick Van Dijck, Jelmer Sjollema, Bruno P.A. Cammue, Katrien Lagrou, Judith Berman, Christophe d’Enfert, David R. Andes, Maiken Cavling Arendrup, Axel A. Brakhage, Richard Calderone, Rafael Cantón, Tom Coenye, Paul Cos, Leah E. Cowen, Mira Edgerton, Ana Espinel‐Ingroff, Scott G. Filler, Mahmoud Ghannoum, Neil A. R. Gow, Hubertus Haas, Mary Ann Jabra‐Rizk, Elizabeth M. Johnson, Shawn R. Lockhart, José L. López-Ribot, Johan Maertens, Carol A. Munro, Jeniel E. Nett, Clarissa J. Nobile, Michael A. Pfaller, Gordon Ramage, Dominique Sanglard, Maurizio Sanguinetti, Isabel Spriet, Paul E. Verweij, Adilia Warris, Joost Wauters, Michael R. Yeaman, Sebastian A. J. Zaat, Karin Thevissen   +38 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients

, 2016
Claes Nøhr Ladefoged, Ian Law, Udunna Anazodo, Keith St. Lawrence, David Izquierdo‐Garcia, Ciprian Catana, Ninon Burgos, M. Jorge Cardoso, Sébastien Ourselin, Brian Hutton, Inès Mérida, Nicolas Costes, Alexander Hammers, Didier Benoit, Søren Holm, Meher R. Juttukonda, Hongyu An, Jorge Cabello, Mathias Lukas, Stephan G. Nekolla, Sibylle Ziegler, Matthias Fenchel, Bjoern Jakoby, Michael Casey, Tammie L.S. Benzinger, Liselotte Højgaard, Adam E. Hansen, Flemming Littrup Andersen   +27 more
openalex   +1 more source